Style | Citing Format |
---|---|
MLA | Sadeghzadeh H, et al.. "Pcl/Col I-Based Magnetic Nanocomposite Scaffold Provides an Osteoinductive Environment for Adscs in Osteogenic Cues-Free Media Conditions." Stem Cell Research and Therapy, vol. 13, no. 1, 2022, pp. -. |
APA | Sadeghzadeh H, Mehdipour A, Dianatmoghadam H, Salehi R, Khoshfetrat AB, Hassani A, Mohammadnejad D (2022). Pcl/Col I-Based Magnetic Nanocomposite Scaffold Provides an Osteoinductive Environment for Adscs in Osteogenic Cues-Free Media Conditions. Stem Cell Research and Therapy, 13(1), -. |
Chicago | Sadeghzadeh H, Mehdipour A, Dianatmoghadam H, Salehi R, Khoshfetrat AB, Hassani A, Mohammadnejad D. "Pcl/Col I-Based Magnetic Nanocomposite Scaffold Provides an Osteoinductive Environment for Adscs in Osteogenic Cues-Free Media Conditions." Stem Cell Research and Therapy 13, no. 1 (2022): -. |
Harvard | Sadeghzadeh H et al. (2022) 'Pcl/Col I-Based Magnetic Nanocomposite Scaffold Provides an Osteoinductive Environment for Adscs in Osteogenic Cues-Free Media Conditions', Stem Cell Research and Therapy, 13(1), pp. -. |
Vancouver | Sadeghzadeh H, Mehdipour A, Dianatmoghadam H, Salehi R, Khoshfetrat AB, Hassani A, et al.. Pcl/Col I-Based Magnetic Nanocomposite Scaffold Provides an Osteoinductive Environment for Adscs in Osteogenic Cues-Free Media Conditions. Stem Cell Research and Therapy. 2022;13(1):-. |
BibTex | @article{ author = {Sadeghzadeh H and Mehdipour A and Dianatmoghadam H and Salehi R and Khoshfetrat AB and Hassani A and Mohammadnejad D}, title = {Pcl/Col I-Based Magnetic Nanocomposite Scaffold Provides an Osteoinductive Environment for Adscs in Osteogenic Cues-Free Media Conditions}, journal = {Stem Cell Research and Therapy}, volume = {13}, number = {1}, pages = {-}, year = {2022} } |
RIS | TY - JOUR AU - Sadeghzadeh H AU - Mehdipour A AU - Dianatmoghadam H AU - Salehi R AU - Khoshfetrat AB AU - Hassani A AU - Mohammadnejad D TI - Pcl/Col I-Based Magnetic Nanocomposite Scaffold Provides an Osteoinductive Environment for Adscs in Osteogenic Cues-Free Media Conditions JO - Stem Cell Research and Therapy VL - 13 IS - 1 SP - EP - PY - 2022 ER - |